Dr. Dusetzina is an associate professor in the Department of Health Policy and an Ingram associate professor of cancer research at Vanderbilt University School of Medicine. She received her PhD in Pharmaceutical Science from the University of North Carolina at Chapel Hill and post-doctoral training at the Department of Health Care Policy at Harvard. She is a health services researcher focusing on the intersection between health policy, epidemiology, and economics related to prescription drugs. Dr. Dusetzina’s work has contributed to the evidence base for the role of drug costs on patient access to care and policy changes that might improve patient access and reduce spending on high-priced drugs, including those used to treat cancer. She has been recognized for her work at a national level, including being an invited participant for two working group meetings on “Patient Access to Affordable Cancer Drugs,” hosted by the President’s Cancer Panel, and being selected to co-author a National Academies of Sciences, Engineering and Medicine report on the same topic. Dr. Dusetzina was recently appointed to the Medicare Payment Advisory Commission and is engaged in national policy related to access to care for Medicare beneficiaries. Dr. Dusetzina will co-direct the project with Dr. Nicholas, who has considerable experience using the Health and Retirement Study to assess economic effects of health.